Sung Won Lee, MD
Internal Medicine · Palisades Park, NJNPI 1144296492
Payments from drug & device makers
Across 750 payments — averaging $15.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- Novo Nordisk$1K
- AstraZeneca$1K
- Scilex Pharmaceuticals Inc.$999
- Boehringer Ingelheim$969
- AbbVie$570
- plus $4K from 33 others
What the payments were for
- Food & beverage$11,60799%
- Education$881%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 140 | $2,198 |
| Novo Nordisk | 101 | $1,352 |
| AstraZeneca(2 entities) | 71 | $1,130 |
| Scilex Pharmaceuticals Inc. | 77 | $999 |
| Boehringer Ingelheim | 37 | $969 |
| AbbVie(2 entities) | 41 | $570 |
| Radius Health, Inc. | 29 | $513 |
| Merck | 33 | $469 |
| Amarin Pharma, Inc. | 37 | $437 |
| Sanofi-aventis U.S. LLC | 17 | $424 |
| Pfizer | 29 | $408 |
| Lilly USA, LLC | 29 | $391 |
| Exact Sciences | 9 | $302 |
| GSK | 18 | $262 |
| Esperion Therapeutics, Inc. | 9 | $129 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $125 |
| Bayer | 7 | $122 |
| Ironwood Pharmaceuticals, Inc | 8 | $115 |
| Johnson & Johnson | 7 | $110 |
| Aimmune Therapeutics, Inc. | 6 | $98 |
| Novartis | 5 | $79 |
| Dexcom, Inc. | 3 | $64 |
| Kowa Pharmaceuticals America, Inc. | 3 | $44 |
| Abiomed | 2 | $43 |
| Sanofi Pasteur Inc. | 3 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $40 |
| Gilead | 3 | $39 |
| Integra Lifesciences Corporation | 1 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| Orexo US, Inc. | 2 | $24 |
| Medtronic | 1 | $21 |
| Alvogen Inc | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Abbott | 1 | $15 |
| Ardelyx, Inc. | 1 | $15 |
| Biogen | 1 | $15 |
| Seqirus USA Inc | 1 | $14 |
| Indivior Inc. | 1 | $13 |
| Genentech USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$500
- SOLIQUA 100/33$125
- EVENITY$125
- Cologuard Collection Kit$125
- FARXIGA$125
- Tymlos$122
- Otezla$120
How this compares
$11,695 in reported general payments places this provider in the 90th percentile of 4,032 internal medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 167 | $430,522 |
| FarxigaDapagliflozin Propanediol | 449 | $394,038 |
| VascepaIcosapent Ethyl | 636 | $277,140 |
| ZenpepLipase/Protease/Amylase | 125 | $251,632 |
| JardianceEmpagliflozin | 222 | $202,785 |
| ProliaDenosumab | 108 | $172,187 |
| OzempicSemaglutide | 146 | $155,668 |
| JanuviaSitagliptin Phosphate | 151 | $136,198 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 129 | $98,816 |
| Xigduo XrDapaglifloz Propaned/Metformin | 95 | $89,347 |
| TrulicityDulaglutide | 66 | $80,875 |
| RybelsusSemaglutide | 63 | $78,599 |
| EliquisApixaban | 67 | $75,673 |
| TradjentaLinagliptin | 77 | $67,717 |
| LinzessLinaclotide | 96 | $64,109 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess, Namzaric | $570 | $554,871354 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,130 | $430,103506 claims |
| Boehringer IngelheimJardiance, Tradjenta, Synjardy Xr, Jentadueto Xr | $969 | $339,836387 claims |
| MerckJanuvia, Janumet Xr, Janumet | $469 | $266,942318 claims |
| Aimmune Therapeutics, Inc.Zenpep | $98 | $251,632125 claims |
| Novo NordiskOzempic, Rybelsus | $1,352 | $234,267209 claims |
| AmgenProlia, Evenity (2 Syringes) | $2,198 | $226,512124 claims |
| PfizerEliquis, Abrysvo | $408 | $87,823110 claims |
| GSKAnoro Ellipta, Breo Ellipta, Incruse Ellipta | $262 | $84,238156 claims |
| Lilly USA, LLCTrulicity | $391 | $80,87566 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $999 | $56,31171 claims |
| GileadVemlidy | $39 | $44,88018 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,032 internal medicine providers in New Jersey.
Other internal medicine in Palisades Park
- Sanjiv SharmaToms River$33.9M
- Jeffrey CarsonNew Brunswick$13.8M
- Samer HaddadHamilton$6.8M
- Magdy ShenoudaWall$3.7M
- Samar HameedLivingston$3.6M
- Jane RohlfTrenton$2.7M
- Mohammed NisarEdison$2.6M
- Michael CasserNew Milford$2.2M
- Sumitha ReddyHamilton$2M
- Helio PedroNewark$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.